(Q34901531)

English

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

restless legs syndrome

0 references

1 reference

based on heuristic

inferred from title

Claudia Trenkwalder

14

object named as

Claudia Trenkwalder

0 references

Karin Stiasny-Kolster

9

object named as

Karin Stiasny-Kolster

0 references

1

object named as

Birgit Högl

0 references

Luigi Ferini Strambi

4

object named as

Luigi Ferini-Strambi

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Viola Gschliesser

10

object named as

Viola Gschliesser

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Birgit Frauscher

12

object named as

Birgit Frauscher

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Richard P Allen

16

object named as

Richard P Allen

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Georgios M Hadjigeorgiou

5

object named as

Georgios Hadjigeorgiou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

object named as

Ralf Kohnen

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Diego García-Borreguero

2

object named as

Diego García-Borreguero

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

13

object named as

Heike Benes

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Magdolna Hornyak

6

object named as

Magdolna Hornyak

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Al de Weerd

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Svenja Happe

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Renata Egatz

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Wayne A Hening

15

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

11 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

257

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

230-237

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Augmentation as a treatment complication of restless legs syndrome: concept and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

The restless legs syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Effective cabergoline treatment in idiopathic restless legs syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

Levodopa in restless legs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

8 July 2018

A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5299-8

21 January 2018

The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Augmentation in restless legs syndrome is associated with low ferritin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Long-term treatment of restless legs syndrome with dopamine agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Augmentation of the restless legs syndrome with carbidopa/levodopa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3085743

26 October 2018

Treatment of restless legs syndrome with levodopa plus benserazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-009-5299-8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34901531&oldid=2199359736"